605507 Guobang Pharma Ltd.
- 17.15
- -0.33-1.89%
Guobang Pharma Ltd. News
Announcement on the Progress of Guobang Pharmaceutical's Repurchase of Shares through Centralized Competitive Trading.
Announcement of Resolutions of the 8th Meeting of the Second Board of Directors of Guobang Pharmaceutical
Announcement of the resolution of the National Pharmaceutical Employee Congress.
Management Measures for the First Phase of Country Union Pharmacy Employee Stock Ownership Plan.
Independent financial advisor report on the first employee stock ownership plan (draft) of Guobang Pharmaceutical Group Co., Ltd. from Rongzheng Enterprise Consulting Services (Group) Co., Ltd. Shanghai.
Legal Opinion of Guohao Law Firm (Hangzhou) on the First Phase Employee Stock Ownership Plan of Guobang Pharmaceutical Group Co., Ltd.
Verification opinion on the first phase of the company's employee shareholding plan by Guobang Pharmaceutical's supervisors.
Draft of the first phase of Guobang Pharmaceutical's employee shareholding plan.
Summary of the first phase of the Guobang Pharmaceutical Employee Stock Ownership Plan (Draft).
Materials for the first extraordinary general meeting of shareholders of Guobang Pharmaceutical in 2024.
Notice on Convening the First Extraordinary Shareholders' Meeting of Guobang Pharmaceutical Co., Ltd. in 2024.
Announcement of the resolution of the 7th meeting of the 2nd Board of Supervisors of Guobang Pharmaceutical
Announcement of the implementation of annual equity distribution of Guobang Pharmaceutical in 2023.
Special Legal Opinion of Guohao Law Firm (Hangzhou) on the Differential Dividend of Guobang Medicine
Guobang Pharmaceutical's progress announcement on the repurchase of shares through centralized bidding
Guobang Pharmaceutical's announcement on adjusting the distribution amount per share of the 2023 profit distribution plan
Guobang Pharmaceutical's announcement on the repurchase ratio of the company's shares reached 1% through centralized bidding transactions and the progress of the repurchase
Announcement of Resolutions of Guobang Pharmaceutical's 2023 Annual General Meeting of Shareholders
Legal Opinion of Guohao Lawyers (Hangzhou) Firm on the 2023 Annual General Meeting of Shareholders of Guobang Pharmaceutical
Guobang Pharmaceutical's indicative announcement on the progress of shareholders' reduction in shareholders' holdings and changes in equity of more than 1%
Analysis
Price Target
No Data
